.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Deloitte
Dow
Accenture
Moodys
McKinsey
US Army
Cerilliant
Chinese Patent Office
Harvard Business School

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 200154

« Back to Dashboard
NDA 200154 describes CISATRACURIUM BESYLATE PRESERVATIVE FREE, which is a drug marketed by Sandoz Inc, Jiangsu Hengrui Med, Accord Hlthcare, and Fresenius Kabi Usa, and is included in four NDAs. It is available from three suppliers. Additional details are available on the CISATRACURIUM BESYLATE PRESERVATIVE FREE profile page.

The generic ingredient in CISATRACURIUM BESYLATE PRESERVATIVE FREE is cisatracurium besylate preservative free. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the cisatracurium besylate preservative free profile page.

Summary for 200154

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0

Pharmacology for NDA: 200154

Suppliers and Packaging for NDA: 200154

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION 200154 ANDA Sandoz Inc 0781-3150 0781-3150-95 10 BOX in 1 CARTON (0781-3150-95) > 1 VIAL in 1 BOX (0781-3150-75) > 5 mL in 1 VIAL
CISATRACURIUM BESYLATE PRESERVATIVE FREE
cisatracurium besylate
INJECTABLE;INJECTION 200154 ANDA Sandoz Inc 0781-3153 0781-3153-95 10 BOX in 1 CARTON (0781-3153-95) > 1 VIAL in 1 BOX (0781-3153-80) > 20 mL in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 2MG BASE/ML
Approval Date:Feb 3, 2012TE:APRLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrengthEQ 10MG BASE/ML
Approval Date:Feb 3, 2012TE:APRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Dow
Colorcon
Queensland Health
Chinese Patent Office
Accenture
Argus Health
QuintilesIMS
Moodys
Federal Trade Commission
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot